BRIEF-Prometic's PBI-4050 significantly reduces liver fibrosis in patients with alström syndrome
Oct 12 Prometic Life Sciences Inc :
* Prometic's PBI-4050 significantly reduces liver fibrosis in patients with alström syndrome
* Prometic Life Sciences-significant reduction of established liver fibrosis demonstrated in all patients that completed 12 weeks of PBI-4050 treatment
* Prometic Life Sciences Inc - liver enzymes reduced to within normal ranges in all patients that completed 12 weeks of PBI-4050 treatment
* Prometic Life Sciences Inc - alström syndrome clinical program to be expanded to include further sites throughout europe and north america
* Prometic Life Sciences-drug safety monitoring board recommended patient enrolment should continue in co's ongoing alström syndrome phase 2 clinical trial Source text for Eikon: Further company coverage:
AT&T reaches deal to buy Time Warner for more than $80 billion -WSJ
Oct 22 AT&T Inc reached a deal to buy media company Time Warner Inc for more than $80 billion, The Wall Street Journal reported on Saturday.
Trump vows to weaken U.S. media 'power structure' if elected
GETTSYBURG, Pa. , Oct 22 U.S. Republican presidential candidate Donald Trump promised on Saturday to foil a proposed deal for AT&T Inc to buy Time Warner Inc if he wins the Nov. 8 election, arguing it was an example of a "power structure" rigged against both him and voters.